Paysign, Inc. (NASDAQ:PAYS) Insider Sells $186,942.03 in Stock

Key Points

• Matthew Louis Lanford, an insider at Paysign, sold shares worth $186,942.03, resulting in a 15.18% decrease in their stock position.
• Paysign recently reported earnings of $0.05 per share, beating analyst expectations, and generated $18.60 million in revenue for the quarter.
• Institutional investors currently own 25.89% of Paysign's shares, with notable recent purchases from firms like Topline Capital Management and Millennium Management.

Paysign, Inc. (NASDAQ:PAYS - Get Free Report) insider Matthew Louis Lanford sold 26,367 shares of the business's stock in a transaction on Monday, August 4th. The stock was sold at an average price of $7.09, for a total value of $186,942.03. Following the transaction, the insider directly owned 147,364 shares of the company's stock, valued at $1,044,810.76. This trade represents a 15.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Paysign Trading Up 0.3%

PAYS stock traded up $0.02 during trading on Monday, reaching $7.16. 949,589 shares of the stock were exchanged, compared to its average volume of 954,471. The firm's 50 day moving average is $6.45 and its 200 day moving average is $3.93. Paysign, Inc. has a twelve month low of $1.80 and a twelve month high of $8.88. The firm has a market cap of $388.22 million, a P/E ratio of 65.10 and a beta of 0.78.

Paysign (NASDAQ:PAYS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. Paysign had a return on equity of 19.49% and a net margin of 9.55%. The business had revenue of $18.60 million for the quarter, compared to the consensus estimate of $17.49 million. As a group, analysts predict that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Topline Capital Management LLC bought a new position in shares of Paysign in the fourth quarter valued at approximately $16,946,000. Renaissance Technologies LLC lifted its holdings in shares of Paysign by 11.0% in the fourth quarter. Renaissance Technologies LLC now owns 1,501,622 shares of the company's stock valued at $4,535,000 after purchasing an additional 149,200 shares in the last quarter. 1248 Management LLC bought a new position in shares of Paysign in the fourth quarter valued at approximately $2,778,000. Millennium Management LLC lifted its holdings in shares of Paysign by 123.6% in the fourth quarter. Millennium Management LLC now owns 325,334 shares of the company's stock valued at $983,000 after purchasing an additional 179,814 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of Paysign by 4.5% in the fourth quarter. Northern Trust Corp now owns 274,005 shares of the company's stock valued at $827,000 after purchasing an additional 11,806 shares in the last quarter. Institutional investors own 25.89% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on PAYS. DA Davidson set a $8.00 price target on Paysign in a report on Friday, June 13th. LADENBURG THALM/SH SH boosted their price target on Paysign from $7.25 to $8.25 and gave the stock a "buy" rating in a report on Friday, May 9th. Finally, Lake Street Capital boosted their price objective on Paysign from $7.00 to $9.00 and gave the stock a "buy" rating in a research report on Thursday, June 26th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.